comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists outcome studies receptor Renal effects of GLP-1 receptor

However, while both medications work through the same general mechanism, Zepbound may include additional active ingredients that provide further benefits, such as improving metabolic function or offering more flexibility in dosing

Although renin was discovered more than a century ago and the detection of angiotensin I, angiotensin II and aldosterone in the 50s allowed the definition of the classical RAAS pathway from 1961 (19), the research in this field continues and new evidence has recently emerged

This is partly due to tirzepatide's mechanism of action as a double agonist, permitting it to assert a more significant decrease in hyperglycemia as compared to glucagon-like peptide (GLP-1) agonists on their own [8]

Koychev I., Reid G., Nguyen M., Mentz R.J., Joyce D., Shah S.H., Holman R.R

Self-Evaluation Questions: Have I consulted with a healthcare provider about my wellness goals